Top Markets
Coin of the day
Zhejiang Starry Pharmaceutical Co.,Ltd. Zhejiang Starry Pharmaceutical Co.,Ltd.

Zhejiang Starry Pharmaceutical Co.,Ltd.

603520
Rank in Stocks #12607
Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry... Founded in 1997 and headquartered in Xianju, China, Zhejiang Starry Pharmaceutical Co.,Ltd. specializes in the research, production, and global distribution of X-CT non-ionic contrast agents and fluoroquinolone pharmaceuticals, along with their key intermediates. The company's extensive range of contrast agent products includes iohexol (and its hydrolysate and iodide derivatives), ioversol, iopamidol, iomeprol, iopromide, cybeclamine, iodixanol, gadopentetic acid dimeglumine, and glutamate. For fluoroquinolones, their offerings feature levofloxacin (and its hydrochloride salt), levoflurane, levofluorocarboxylic acid, pazufloxacin, and pazufloxacin mesylate.
Share Price
$1.29
Market Cap
$567.34M
Change (1 day)
-1.33%
Change (1 year)
-20.72%
Country
CN
Trade Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)

Category

Dividend history for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520)
Zhejiang Starry Pharmaceutical Co.,Ltd. (stock symbol: 603520) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Zhejiang Starry Pharmaceutical Co.,Ltd. (603520) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors